Healthcare IT News September 30, 2021
Kat Jercich

The expanded dataset could enable researchers to gain insights about “long COVID,” says CEO of the landmark personalized medicine project.

The National Institutes of Health’s All of Us research program announced this past week that it had made a significant increase in the COVID-19 information available in its precision medicine database.

The expanded COVID-19 survey dataset now includes responses from nearly 100,000 participants, which could allow researchers to glean new insights from the wide-ranging information.

This means the program’s researcher workbench now includes data from 329,000 people, 80% of whom represent communities underrepresented in medical research.

“It’s a really diverse community,” All of Us Chief Executive Officer Josh Denny told Healthcare IT News. “They’re very engaged, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Transforming public health: a physician’s innovative approach [PODCAST]
Trump Nominates Physicians for CDC Director, Surgeon General
5 Things You Should Know About Long COVID
Q&A: How school eligibility influences the spread of infectious diseases

Share This Article